Artificial Pancreas Market by Type and Geography - Forecast and Analysis 2022-2026
- Published: Jan 2022
- Pages: 120
- SKU: IRTNTR72088
Enjoy complimentary customisation on priority with our Enterprise License!
One user only.
Quick & easy download option
Unlimited user access (Within your organization)
Complimentary Customization Included
The artificial pancreas market share is expected to increase by USD 450.95 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 19.15%.
This artificial pancreas market research report extensively covers artificial pancreas market segmentation by type (threshold suspend device, non-threshold suspend device, control to range system, and control to target system) and geography (North America, Europe, Asia, and ROW). The artificial pancreas market report also offers information on several market vendors, including Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc. among others.
What will the Artificial Pancreas Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Artificial Pancreas Market Size for the Forecast Period and Other Important Statistics
Artificial Pancreas Market: Key Drivers, Trends, and Challenges
The rising global burden of diabetes is notably driving the artificial pancreas market growth, although factors such as stringent regulatory framework may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the artificial pancreas industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Artificial Pancreas Market Driver
One of the key factors driving growth in the artificial pancreas market is the rising global burden of diabetes. Diabetes is a chronic disease, which occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin. Hyperglycemia or increased blood sugar can result in severe damage or complications that may become life-threatening for the individual if left untreated. The global burden of the disease is rising at a rapid pace. The growing incidence of both type 1 and type 2 diabetes will significantly increase healthcare costs across the world. The factors contributing to the increase in the diabetic population include obesity, smoking, a sedentary lifestyle, and growing urbanization. Furthermore, the incidence of diabetes is higher in the case of the older population. Countries with a higher population base like China and India are likely to have a higher incidence of diabetes owing to an increase in obesity levels and urbanization. Thus, the increasing incidence of diabetes worldwide is likely to drive the market with the increased adoption of an artificial pancreas.
Key Artificial Pancreas Market Trend
The increase in awareness programs for diabetes is another factor supporting the artificial pancreas market share growth. Vendors are organizing summits to spread awareness about diabetes as well as generate insights for product development. For instance, the European Foundation for the Study of Diabetes (EFSD) in Europe is a leading European funding agency for diabetes research, which aims at creating and spreading awareness of type 1 diabetes among people. The Juvenile Diabetes Research Foundation (JDRF) is fighting type 1 diabetes by funding research, advocating for policies that improve patient access to drugs, and providing a single support network for patients with type 1 diabetes. Various initiatives taken to increase the awareness of diabetes management in the region will also accelerate the growth of the market during the forecast period. Such initiatives provide participants with knowledge of various tools and daily routine activities for diabetes prevention, management, and control. This will further enhance the demand for artificial pancreas among diabetic patients, which, in turn, will drive the growth of the market.
Key Artificial Pancreas Market Challenge
The stringent regulatory framework will be a major challenge for the artificial pancreas market during the forecast period. Medical device-related regulations must be improved to ensure that high-quality, efficient, and safe technologies reach consumers. The growing number and modernization of medical devices have led to new regulatory challenges. The US FDA has classified diabetes care management devices, such as insulin pumps, infusion sets, and insulin bolus, under the Class II category of medical devices. Failure to adhere to the US FDA regulations or any complications caused by the use of artificial pancreas will lead to the recall of the product, which will significantly affect the company's brand name. In Europe and the US, regulations, including those for medical devices, focus on deploying robust surveillance systems, enhancing post-market regulations, strengthening the regulatory process, and improving monitoring of such devices. Market vendors that are focusing on adopting innovative technologies and designing novel products should undergo stringent post-market approvals prior to the launch of the products. Therefore, the stringent regulatory scenario could potentially hamper the artificial pancreas market.
This artificial pancreas market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global artificial pancreas market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the artificial pancreas market during the forecast period.
Who are the Major Artificial Pancreas Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Admetsys Corp.
- Beta Bionics Inc.
- Bigfoot Biomedical Inc.
- Defymed SAS
- Dexcom Inc.
- Inreda Diabetic B.V.
- Insulet Corp.
- Medtech Life Pvt. Ltd.
- Medtronic Plc
- Tandem Diabetes Care Inc.
This statistical study of the artificial pancreas market encompasses successful business strategies deployed by the key vendors. The artificial pancreas market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
Admetsys Corp - The company offers artificial pancreas such as the closed-loop artificial pancreas.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The artificial pancreas market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Artificial Pancreas Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the artificial pancreas market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare supplies market includes the following core components:
- Outbound logistics
- Marketing and sales
- Post-sales and services
- Industry innovations
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
Which are the Key Regions for Artificial Pancreas Market?
For more insights on the market share of various regions Request for a FREE sample now!
43% of the market's growth will originate from North America during the forecast period. The US is the key market for artificial pancreas in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.
The increase in technological advances and a high incidence of type 1 and type 2 diabetes will facilitate the artificial pancreas market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 adversely affected all the countries in North America, especially the US, in 2020. However, it had only a slightly negative impact on the artificial pancreas market in North America. By the second half of 2020, the lockdown-related restrictions were somewhat relaxed in various countries, which included the resumption of businesses and non-essential services. Thus, the resumption of healthcare equipment manufacturing will cater to the demand for artificial pancreas in North America through both online and offline channels, and the market in focus will register an accelerating growth momentum during the forecast period
What are the Revenue-generating Type Segments in the Artificial Pancreas Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The artificial pancreas market share growth by the threshold suspend device segment will be significant during the forecast period. Threshold suspend is a Continuous Glucose Monitor (CGM) enabled feature that is designed to automatically stop insulin delivery when the sensor value reaches or falls below a pre-set threshold. This increases the demand for threshold suspends device systems among diabetic patients. Therefore the segment is expected to grow during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the artificial pancreas market size and actionable market insights on post COVID-19 impact on each segment.
Artificial Pancreas Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 19.15%
Market growth 2022-2026
$ 450.95 million
YoY growth (%)
North America, Europe, Asia, and ROW
Performing market contribution
North America at 43%
Key consumer countries
US, Germany, France, China, and UK
Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled
Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
What are the Key Data Covered in this Artificial Pancreas Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive artificial pancreas market growth during the next five years
- Precise estimation of the artificial pancreas market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the artificial pancreas industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of artificial pancreas market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1. Executive Summary
1.1 Market Overview
Exhibit 01: Key Finding 1
Exhibit 02: Key Finding 2
Exhibit 03: Key Finding 3
Exhibit 04: Key Finding 5
Exhibit 05: Key Finding 6
Exhibit 06: Key Finding 7
Exhibit 07: Key Finding 8
2. Market Landscape
2.1 Market ecosystem
2.1.1 Parent Market
Exhibit 08 Parent market
Exhibit 09: Market characteristics
2.2 Value Chain Analysis
Exhibit 10: Value Chain Analysis: Healthcare Supplies
2.2.4 Outbound logistics
2.2.5 Marketing and sales
2.2.6 Post-sales and services
2.2.7 Industry innovations
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021 - 2026
3.4.1Estimating growth rates for emerging and high-growth markets
3.4.2Estimating growth rates for mature markets
Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
Exhibit 14: Global market: Year-over-year growth 2021 - 2026 (%)
4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 15: Five forces analysis 2021 - 2026
4.2 Bargaining power of buyers
Exhibit 16: Bargaining power of the buyer
4.3 Bargaining power of suppliers
Exhibit 17: Bargaining power of the supplier
4.4 Threat of new entrants
Exhibit 18: Threat of new entrants
4.5 Threat of substitutes
Exhibit 19: Threat of substitutes
4.6 Threat of rivalry
Exhibit 20: Threat of rivalry
4.7 Market condition
Exhibit 21: Market condition - Five forces 2021
5. Market Segmentation by Type
5.1 Market segments
Exhibit 22: Type- Market share 2021 - 2026 (%)
5.2 Comparison by Type
Exhibit 23: Comparison by Type
5.3 Threshold suspend device - Market size and forecast 2021-2026
Exhibit 24: Threshold suspend device - Market size and forecast 2021-2026 ($ million)
Exhibit 25: Threshold suspend device - Year-over-year growth 2021-2026 (%)
5.4 Non-threshold suspend device - Market size and forecast 2021-2026
Exhibit 26: Non-threshold suspend device - Market size and forecast 2021-2026 ($ million)
Exhibit 27: Non-threshold suspend device - Year-over-year growth 2021-2026 (%)
5.5 Control to range system - Market size and forecast 2021-2026
Exhibit 28: Control to range system - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Control to range system - Year-over-year growth 2021-2026 (%)
5.6 Control to target system - Market size and forecast 2021-2026
Exhibit 30: Control to target system - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Control to target system - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Type
Exhibit 32: Market opportunity by Type
6. Customer landscape
Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
Exhibit 33: Customer landscape
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 34: Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 35: Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 36: North America - Market size and forecast 2021-2026 ($ million)
Exhibit 37: North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 38: Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 39: Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 40: Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Asia - Year-over-year growth 2021-2026 (%)
7.6 ROW - Market size and forecast 2021-2026
Exhibit 42: ROW - Market size and forecast 2021-2026 ($ million)
Exhibit 43: ROW - Year-over-year growth 2021-2026 (%)
7.7 Key leading countries
Exhibit 44: Key leading countries
7.8 Market opportunity by geography
Exhibit 45: Market opportunity by geography ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Rising global burden of diabetes
Exhibit 46: Prevalence of diabetes 2000 and 2030 (million)
8.1.2 Favorable regulations and guidelines
8.1.3 Rising geriatric population
8.2 Market challenges
8.2.1 Stringent regulatory framework
8.2.2 Low penetration rates
8.2.3 High cost of artificial pancreas
Exhibit 47: Impact of drivers and challenges
8.3 Market trends
8.3.1 Increase in awareness programs for diabetes
8.3.2 Growing technological integration
8.3.3 Rising strategic partnerships to boost sales of artificial pancreas
9. Vendor Landscape
Exhibit 48: Vendor landscape
9.2 Landscape disruption
Exhibit 49: Landscape disruption
Exhibit 50: Industry Risk
10. Vendor Analysis
10.1 Vendors covered
Exhibit 51: Vendors covered
10.2 Market positioning of vendors
Exhibit 52: ?Market positioning of vendors?
10.3 Admetsys Corp.
Exhibit 53: Admetsys Corp. - Overview
Exhibit 54: Admetsys Corp. - Product and service
Exhibit 55: Admetsys Corp. - Key offerings
10.4 Beta Bionics Inc.
Exhibit 56: Beta Bionics Inc. - Overview
Exhibit 57: Beta Bionics Inc. - Business segments
Exhibit 58: Beta Bionics Inc. - Key news
Exhibit 59: Beta Bionics Inc. - Key offerings
Exhibit 60: Beta Bionics Inc. - Segment focus
10.5 Bigfoot Biomedical Inc.
Exhibit 61: Bigfoot Biomedical Inc. - Overview
Exhibit 62: Bigfoot Biomedical Inc. - Product and service
Exhibit 63: Bigfoot Biomedical Inc. - Key offerings
10.6 Defymed SAS
Exhibit 64: Defymed SAS - Overview
Exhibit 65: Defymed SAS - Product and service
Exhibit 66: Defymed SAS - Key offerings
10.7 Dexcom Inc.
Exhibit 67: Dexcom Inc. - Overview
Exhibit 68: Dexcom Inc. - Business segments
Exhibit 69: Dexcom Inc. - Key offerings
Exhibit 70: Dexcom Inc. - Segment focus
10.8 Inreda Diabetic B.V.
Exhibit 71: Inreda Diabetic B.V. - Overview
Exhibit 72: Inreda Diabetic B.V. - Product and service
Exhibit 73: Inreda Diabetic B.V. - Key offerings
10.9 Insulet Corp.
Exhibit 74: Insulet Corp. - Overview
Exhibit 75: Insulet Corp. - Business segments\
Exhibit 76: Insulet Corp. - Key offerings
Exhibit 77: Insulet Corp. - Segment focus
10.10 Medtech Life Pvt. Ltd.
Exhibit 78: Medtech Life Pvt. Ltd. - Overview
Exhibit 79: Medtech Life Pvt. Ltd. - Product and service
Exhibit 80: Medtech Life Pvt. Ltd. - Key offerings
10.11 Medtronic Plc
Exhibit 81: Medtronic Plc - Overview
Exhibit 82: Medtronic Plc - Business segments
Exhibit 83: Medtronic Plc - Key offerings
Exhibit 84: Medtronic Plc - Segment focus
10.12 Tandem Diabetes Care Inc.
Exhibit 85: Tandem Diabetes Care Inc. - Overview
Exhibit 86: Tandem Diabetes Care Inc. - Business segments
Exhibit 87: Tandem Diabetes Care Inc. - Key offerings
Exhibit 88: Tandem Diabetes Care Inc. - Segment focus
11.1 Scope of the report
11.1.1 ????Market definition
11.1.3 ????Notes and caveats
11.2 Currency conversion rates for US$
Exhibit 89: ?Currency conversion rates for US$?
11.3 Research Methodology
Exhibit 90: ?Research Methodology
Exhibit 91: ??Validation techniques employed for market sizing?
Exhibit 92: ??Information sources
11.4 List of abbreviations
Exhibit 93: List of abbreviations
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
- Collation of data
- Estimation of key figures
- Analysis of derived insights
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get your sample now!
Frequently Asked Questions?
- Rising global burden of diabetes
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
One user only.
Quick & easy download option
Unlimited user access (Within your organization)
Complimentary Customization Included
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts